Association of Systemic Inflammation with Depressive Symptoms in Individuals with COPD
Hilary C Strollo,Seyed M Nouraie,Karin F Hoth,Craig M Riley,Chad Karoleski,Yingze Zhang,Nicola A Hanania,Russell P Bowler,Jessica Bon,Frank C Sciurba
DOI: https://doi.org/10.2147/COPD.S322144
2021-09-03
International Journal of COPD
Abstract:Hilary C Strollo, 1 Seyed M Nouraie, 1 Karin F Hoth, 2 Craig M Riley, 3 Chad Karoleski, 1 Yingze Zhang, 1 Nicola A Hanania, 4 Russell P Bowler, 5, 6 Jessica Bon, 1 Frank C Sciurba 1 1 University of Pittsburgh Medical Center, Department of Medicine, Department of Pulmonary Allergy and Critical Care Medicine, Pittsburgh, PA, USA; 2 University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA, USA; 3 Chester County Hospital, University of Pennsylvania Health System, West Chester, PA, USA; 4 Baylor College of Medicine, Department of Pulmonary, Critical Care and Sleep Medicine, Houston, TX, USA; 5 National Jewish Health, Department of Medicine, Denver, CO, USA; 6 University of Colorado School of Medicine, Denver, CO, USA Correspondence: Hilary C Strollo University of Pittsburgh Medical Center, Department of Medicine, Department of Pulmonary Allergy and Critical Care Medicine, NW 628 UPMC Montefiore, 3459 Fifth Avenue, Pittsburgh, PA, 15213, USA Tel +1 412-692-2210 Fax +1 412-692-4842 Email Rationale: Depression is a prevalent comorbidity of chronic obstructive pulmonary disease (COPD) that, along with COPD, has been associated with inflammation. An association between inflammation and depression in COPD has not been validated in a large COPD cohort. Methods: Individuals from the University of Pittsburgh SCCOR cohort and the COPDGene cohort with tobacco use history and airway obstruction (FEV 1 /FVC < 0.7) were evaluated using the Beck Depression Inventory II (BDI-II) and the Hospital Anxiety and Depression Scale (HADS), respectively. Participants completed symptom-related questionnaires and plasma IL-6 measurements. T -test, Fisher's Exact tests and logistic regression were used for statistical analysis. Results: The SCCOR cohort included 220 obstructed participants: 44% female and 21.4% with elevated depressive symptoms. GOLD staging distribution was predominantly stage I and II. The COPDGene cohort included 745 obstructed participants: 44% female and 13.0% with elevated depressive symptoms. GOLD distribution was predominantly stage II and III. In the SCCOR cohort, correlation between IL-6 and depressive symptoms trended toward significance (p= 0.08). Multivariable modeling adjusted for FEV 1 , age, gender and medical comorbidities showed a significant association (OR = 1.70, 95% CI = 1.08– 2.69). IL-6 was significantly associated with elevated depressive symptoms in COPDGene in both univariate (p=0.001) and multivariable modeling (OR = 1.52, 95% CI =1.13– 2.04). Conclusion: Elevated plasma IL-6 levels are associated with depressive symptoms in individuals with COPD independent of airflow limitation and comorbid risk factors for depression. Our results suggest that systemic inflammation may play a significant and possibly bidirectional role in depression associated with COPD. Keywords: IL-6, depression, beck depression inventory, BDI, HADS, TNF-a, CRP, SCCOR, COPDGene Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease contributing to significant worldwide morbidity and mortality. 1 The complex pathogenesis of COPD includes airway inflammation that ultimately results in airway obstruction. 2 Moreover, COPD has strong associations with a host of comorbidities including depression. 2–6 The estimated global prevalence of depression is less than 10%; however, in stable COPD patients the prevalence of depression is 6–42%. 7–12 Depression in COPD has been associated with worse patient reported outcomes, poor adherence to medical therapy and increased mortality. 13–19 Prior studies have documented that patients with COPD have elevated systemic inflammatory markers including C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), activated leukocytes and fibrinogen. 20–28 Likewise, recent literature has shown that adults with major depressive disorder have associated elevations of IL-1ß, IL-6 and CRP. 29–36 A link between systemic inflammation and depression in individuals with COPD has not been conclusively established. Lu et al found that severity of airflow limitation defined as decreased FEV 1 % predicted and FEV 1 /FVC was associated with both inflammation (ie, IL-6, CRP) and depressive symptoms. 24 Conversely, several studies have found no clear association between IL-6 and depression in the setting of COPD. Hanania et al found no correlation between IL-6 and depression scores in a cohort of individuals with moderate to severe COPD. 37 Li -Abstract Truncated-